Boston Pharmaceuticals Presents Data at NASH-TAG 2024 Demonstrating Low Immunogenicity Over Time With Long-acting FGF21 Analogue, BOS-580, for MASH
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 5, 2024--
Source: eagletribune.com
Stay updated with breaking news from Immunogenicity Reported. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 5, 2024--